Beijing Scitop Bio-Tech300858.SZValuation Analysis

As of Oct 19, 2026, Beijing Scitop Bio-Tech (300858.SZ) trades at a P/E of 47.00x, P/B of 2.06x, P/S of 10.90x, and a dividend yield of 0.71%.
Longitudinal percentile comparison: P/E sits at the 58th percentile over the trailing 10Y window (vs. 55th percentile over 3Y); P/B sits at the 7th percentile over the trailing 10Y window (vs. 14th percentile over 3Y); P/S sits at the 5th percentile over the trailing 10Y window (vs. 4th percentile over 3Y).
Cross-sectional valuation: its P/E ranks at the 76th percentile within its industry and the 59th percentile across the broader market.
Shareholder return highlight: Total Shareholder Yield is 0.71%, ranking at the 21st percentile over the trailing 20Y window.
Notably, P/E and P/B aren't telling quite the same story, 51.2 points apart — worth checking the full percentile matrix on this page for the complete picture. The P/E percentile sits lower across the market than within its own industry — relatively cheaper next to the market as a whole. Shareholder returns here are driven almost entirely by cash dividends, with minimal contribution from buybacks. Beijing Scitop Bio-Tech operates in the Food and Beverage sector. Data refreshes weekly and is for reference only, not investment advice.